Intriguing, while it has been demonstrated that all RASGAPs contain an active GAP domain, our data only identifies NF1 as a bona fide amplifier of RAS-mediated MAPK signaling in patient-derived CRC organoids. This evidence concerns the gene RASA1 and colorectal carcinoma.